Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
888.48
+3.47 (+0.39%)
Streaming Delayed Price
Updated: 1:09 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
83
84
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
April 09, 2024
Via
Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
April 09, 2024
Via
Benzinga
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April
April 09, 2024
These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.
Via
InvestorPlace
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 09, 2024
These companies are close to launching new products that could supercharge revenue.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
These stocks, a bargain today, are players to hold on to for the long term.
Via
The Motley Fool
Understanding Eli Lilly and Co's Position In Pharmaceuticals Industry Compared To Competitors
April 05, 2024
Via
Benzinga
Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment
April 05, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
April 03, 2024
Via
Benzinga
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
April 08, 2024
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a...
Via
Benzinga
2 Growth Stocks to Buy Hand Over Fist in April
April 08, 2024
These healthcare companies' target markets substantially overlap.
Via
The Motley Fool
This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market
April 08, 2024
Lilly's stock has climbed in the triple digits over the past 12 months.
Via
The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
April 08, 2024
Shares of the clinical-stage biotech have skyrocketed on recent good news.
Via
The Motley Fool
Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
April 07, 2024
New findings could lead to more growth from their prized medicines.
Via
The Motley Fool
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
April 06, 2024
Things are going exactly as planned for the biotech giant.
Via
The Motley Fool
Traders Rethink Interest Rate Cuts, Labor Market Heats Up, Oil Prices Quietly Reach 6-Month High: This Week In The Markets
April 05, 2024
U.S. economy resilient, manufacturing and labor market strong. Fed officials temper rate cut expectations. Apple shifts focus to home robotics.
Via
Benzinga
Topics
Economy
Exposures
Economy
Interest Rates
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
April 05, 2024
Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer but lower yield, while high-yield bonds offer higher returns but from...
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
Spring 2024 Snapshot Of The S&P 500's Market Cap
April 04, 2024
The first quarter of 2024 has come and gone. Before it did, the S&P 500 clocked a new record high of 5,254.35.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
April 04, 2024
Here are three Magnificent 7 contenders growth investors shouldn't be sleeping on right now, given their long-term potential.
Via
InvestorPlace
7 A-Rated Stocks to Buy in April
April 04, 2024
These A-rated stocks to buy for April will help you forget about the pain of tax season. Instead, enjoy the profits from these top stocks.
Via
InvestorPlace
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
April 04, 2024
Viking shares have soared recently on optimism about its program.
Via
The Motley Fool
Why Eli Lilly Stock Topped the Market Today
April 03, 2024
One analyst following the company believes it could grow its revenue meaningfully this year.
Via
The Motley Fool
The 3 Best Healthcare Stocks to Buy in April 2024
April 03, 2024
The healthcare industry is not going to stop growing anytime soon. These are the best healthcare stocks to buy in April.
Via
InvestorPlace
Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
April 03, 2024
Eli Lilly's stock skyrockets but now trading sideways as demand for weight-loss drugs outpaces supply. Availability issues lead to FDA shortages.
Via
Benzinga
Exposures
Product Safety
Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China
April 03, 2024
Novo Nordisk warns of Ozempic starter kit scarcity in Germany amid ongoing supply challenges in Europe. Restrictions on off-label use emphasized, with intermittent shortages expected in 2024....
Via
Benzinga
Exposures
Product Safety
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
April 03, 2024
Costco's new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179.
Via
Benzinga
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
AstraZeneca's CEO Pascal Soriot celebrates hitting a $45 billion sales target set a decade ago despite initial skepticism. Investor confidence remains a challenge amid stagnant shares and concerns over...
Via
Benzinga
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand
April 02, 2024
Citi Research raises price target for Eli Lilly, citing improved risk-adjusted sales outlook for GLP-1 agonist orforglipron. With Phase 3 trials ongoing since 2023, concerns about liver toxicity...
Via
Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
83
84
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.